| 496 |
Stressor:491 soluble IL-1R (Rilonacept)
|
|
None
|
| 497 |
Stressor:492 Dexamethasone
|
|
None
|
| 633 |
Stressor:624 SARS-CoV-2
|
|
379: Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
|
| 663 |
Stressor:645 Cigarette smoke
|
|
None
|
| 362 |
Styrene
|
-
Styrene, CAS-RN: 100-42-5, DTXSID2021284
|
None
|
| 653 |
su5402
|
-
su5402, CAS-RN: 215543-92-3, DTXSID90415361
|
None
|
| 402 |
Suberoylanilide hydroxamic acid
|
-
Suberoylanilide hydroxamic acid, CAS-RN: 149647-78-9, DTXSID6041133
|
274: Histone deacetylase inhibition leads to impeded craniofacial development
|
| 79 |
Sulfamethazine
|
-
Sulfamethazine, CAS-RN: 57-68-1, DTXSID6021290
|
None
|
| 434 |
Sulforaphane
|
-
Sulforaphane, CAS-RN: 4478-93-7, DTXSID8036732
|
None
|
| 658 |
Sulfur dioxide
|
-
Sulfur dioxide, CAS-RN: 7446-09-5, DTXSID6029672
|
None
|
| 431 |
Sulindac
|
-
Sulindac, CAS-RN: 38194-50-2, DTXSID4023624
|
None
|
| 169 |
Sunitinib malate Sunitinib (INN)
|
|
43: Disruption of VEGFR Signaling Leading to Developmental Defects
|
| 498 |
Sunlight (wavelength: 290-700 nm)
|
|
None
|
| 114 |
T-butyl bicyclophosphorothionate
|
|
None
|
| 818 |
Tabun
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 163 |
Tacrolimus (also FK506)
|
-
Tacrolimus, CAS-RN: 104987-11-3, DTXSID5046354
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 293 |
Tacrorimus
|
|
None
|
| 616 |
TAK-242
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 172 |
Tamoxifen
|
-
Tamoxifen, CAS-RN: 10540-29-1, DTXSID1034187
|
3 AOPs
|
| 736 |
Tamoxifen epoxide
|
-
Tamoxifen epoxide, CAS-RN: 92137-93-4, DTXSID40238885
|
None
|
| 251 |
TCPOBOP
|
|
107: Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
|
| 286 |
Tebuconazole
|
-
Tebuconazole, CAS-RN: 107534-96-3, DTXSID9032113
|
None
|
| 164 |
Tebufenozide
|
-
Tebufenozide, CAS-RN: 112410-23-8, DTXSID4034948
|
2 AOPs
|
| 852 |
Tebufenpyrad
|
-
Tebufenpyrad, CAS-RN: 119168-77-3, DTXSID0034223
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 827 |
Technical chlordane
|
-
Technical chlordane, CAS-RN: 12789-03-6, DTXSID5023954
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|